EUCAST
https://www.eucast.org/
EUCASTEUCAST
https://www.eucast.org/
https://www.eucast.org/The 2023 preliminary breakpoint table now available for comments and questions.
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=515&cHash=2961158b181e64764129eb13ec57d065
The next breakpoint table (valid from 1 Jan, 2023) is now available for comments and questions....VIPcheck poor and irregular performance warning
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=511&cHash=c28f7bd73418bf0d43daef1c0b298ba7
VIPcheck.In May, 2022, the EUCAST development laboratory for fungi, noticed variable...Breakpoints and methods for C. diphtheriae and C. ulcerans available
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=510&cHash=870956d8fb98979f9bd23167e1a7dba6
The breakpoint table v 13.0 (2023) is under preparation (release for consultation 5 December,...New consultations available
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=509&cHash=94a51174842b9d6f31e29fafac09fa30
Consultations for 26 September to 7 November posted. Go to the Consultations page.
Cefiderocol testing, continued
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=505&cHash=f0e2562c156a6ce5b799106f99b06088
The EUCAST Development Laboratory is currently investigating the accuracy and reproducibility of...EUCAST panels for validating AST methods
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=503&cHash=bc9a75ae5d6e9ed6932496bba8cd7a86
EUCAST in collaboration with CCUG (the Culture Collection of the University of Gothenburg, Sweden),...Updated warning on cefiderocol AST
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=502&cHash=bd859430b55b7a2e3f1ca2f0175af041
Investigations into the problems with susceptibility testing of species with breakpoints for...Corynebacterium consultation - amendments and corrections posted
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=501&cHash=abd89762266d040511eef99a4ede347c
Since the Corynebacterium diphtheriae and C. ulcerans consultation was posted, a few...SOPs 3, 4, 7, 8 and 9 updated.
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=500&cHash=3652716dd0a4d78540870d12b8506e66
Regular updates at set intervals of SOPs 3, 4, 7, 8 and 9.Tigecycline rationale and guidance documents
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=499&cHash=0a642c19e8dbe2475ea3c264a7bcde80
Tigecycline rationale and guidance documentswere revised.General consultation on proposed revision of chloramphenicol breakpoints
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=498&cHash=3aa92bfb18c65fbd236d0676d4f696ca
In a public consultation, EUCAST is asking for views on the proposed revision to chloramphenicol...Fosfomycin - revised MIC distributions and ECOFFs
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=497&cHash=1174a82fe6e2b9c355e33c3014c67ab4
Fosfomycin: as part of the consultation process new fosfomycin MIC data was submitted. The old and...Selective susceptibility testing and reporting
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=496&cHash=9cf91f9961eed65eadf5e0481a36aefc
EUCAST still receives comments from colleagues in clinical microbiology that when organisms are...Consultation on Breakpoints for C. diphtheriae and C. ulcerans.
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=495&cHash=f095ee19b7a59634d98c55be4f964b57
The EUCAST general consultation on Corynebacterium diphtheriae and C. ulcerans is open for...Publication from the AFST 2022
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=494&cHash=0f4c26382935c5edccb4e7d9f5698dbd
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and...Cefiderocol susceptibility testing
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=493&cHash=22779384b74c8cf2c55aa3f7fd69d173
Warning issued concerning cefiderocol susceptibility testing: there is currently no commercially...Screening for azole and echinocandin resistance
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=492&cHash=f0d89d1ec647b2db54307f2be14bed98
Screening for azole and echinocandin resistanceexemplified in AspergillusWarning against using material and devices for AST of species not listed as validated.
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=491&cHash=23c0bc9bbc2ea355fce0bfebf64c27d0
General warning against incomplete species and concentration range validation of commercially...Consultation (14 May - 15 June, extended to 15 July) on revised breakpoints for IV fosfomycin
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=490&cHash=f0df73530e347fe47262a532cde23bb8
EUCAST posted a general consultation on revised breakpoints for intravenous fosfomycin....Consultation on the availability of piperacillin and ticarcillin without inhibitors.
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=488&cHash=f3e61e3f92d3ebe97d34ee2db3dadca3
EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin...A new version of the QC table for testing of antifungal agents is available
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=487&cHash=53e14a0f1c9253d4d6ac446c07e66ede
A new version of the QC table for testing of antifungal agents is available on the website.
Cefiderocol Rationale Document updated
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=485&cHash=340857366db12871bcea51c1da45c157
The Cefiderocol Rational Document has been revised. Link.
RAST updated to include incubation beyond 8 hours
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=484&cHash=309307a01b56067919356090742df5c0
EUCAST Rapid AST directly from positive blood culture bottles, previously restricted to 4, 6 or 8...Guidance note on topical agents revised
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=483&cHash=a21d2d2a29410b3e73e1ae3b3d8c3593
Minor revision of the EUCAST Guidance on topical agentsHow to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values. CMI 2022.
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=482&cHash=33c06c2750a843056a5ec64da3321a12
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff...New version of Broth microdilution of moulds (vs. 9.4)
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=481&cHash=8c2e4a8022c212c27ad80e1f24a475e7
A new version of the Broth microdilution of moulds (version 9.4 to replace 9.3) published 1 April,...EUCAST abandons the term "intrinsic resistance" in favor of "expected resistant phenotype"
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=480&cHash=e6a33871b9efef82225399f1a3ce0493
For many years EUCAST and other committees have struggled with the term “intrinsic resistance”....Cefiderocol disk diffusion with EUCAST criteria - publication in JAC
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=479&cHash=309ce0555892a83c94aef216eb4cf802
Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial...Temocillin MIC vs. inhibition zone diameters
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=478&cHash=af74f97c7b3b6e473de62ad28088b89e
MIC and zone diameter data on temocillin added to the Enterobacterales calibration/validation file...A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
https://www.eucast.org//eucast_news/news_singleview?tx_ttnews%5Btt_news%5D=477&cHash=a27a786fb6cfe130e20193bdb093a5ca
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical...